B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Conditions: Pediatric Solid Tumor; Germ Cell Tumor; Retinoblastoma; Hepatoblastoma; Wilms Tumor; Rhabdoid Tumor; Carcinoma; Osteosarcoma; Ewing Sarcoma; Rhabdomyosarcoma; Synovial Sarcoma; Clear Cell Sarcoma; Malignant Peripheral Nerve Sheath Tumors; Desm oplastic Small Round Cell Tumor; Soft Tissue Sarcoma; Neuroblastoma; Melanoma Interventions: Biological: second generation 4-1BBζ B7H3-EGFRt-DHFR; Biological: second generation 4-1BBζ B7H3-EGFRt-DHFR(selected) and a second generation 4-1BBζ CD19-Her2tG Sponsor: Seattle Children's Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Brain | Cancer & Oncology | Carcinoma | Children | Eye Cancers | Hepatoblastoma | Hospitals | Immunotherapy | Melanoma | Neuroblastoma | Neurology | Osteosarcoma | Pediatrics | Research | Retinoblastoma | Rhabdomyosarcoma | Sarcomas | Skin Cancer